Cross-matching of records between Singapore's tuberculosis and HIV registries showed that 3.3% of individuals with tuberculosis (TB) were coinfected with HIV (2000À2014), the TB incidence among individuals with HIV infection was 1.65 per 100 person-years, and 53% of coinfections were diagnosed within 1 month of each other. The findings supported joint prevention programmes for early diagnosis and treatment.
Introduction
Tuberculosis (TB) and HIV pose a dual epidemic threat to global health [1] . Trends of these two diseases in Singapore indicate that TB and HIV coinfection poses a potential public health threat. The TB incidence rate in Singapore residents has markedly declined in the past decades, and is the lowest rate among South-East Asian countries [2] . However, it is still much higher than that in many developed countries [3] . The HIV prevalence among Singaporean adults (≥ 15 years old) in 2014 was 0.15% [4] compared to 0.3% and 0.1% in the SouthEast Asia and Western Pacific regions, respectively [5] .
In our study, we describe the demographic and clinical characteristics of TB and HIV coinfections in Singapore, and discuss the implications related to public health policy and disease surveillance.
Methods
In Singapore, TB and HIV are notifiable under the Infectious Diseases Act. All suspected and confirmed TB cases are notified to the national TB registry within 72 hours of starting TB treatment and/or receiving laboratory confirmation by acid-fast bacillus smear followed by mycobacterial culture [2] . First-line drug-susceptibility testing (DST) (i.e. susceptibility to streptomycin, rifampicin, isoniazid and ethambutol) is performed for positive TB isolates. Isolates resistant to isoniazid and/or rifampicin are subjected to second-line DST.
HIV/AIDS cases are notified to the National Public Health Unit of the Ministry of Health (MOH). HIV screening is performed using enzyme immunoassays or rapid diagnostic tests, followed by a confirmatory western blot test for positive results.
Both registries contain information on demographics, such as age at diagnosis, gender, ethnicity, occupation, country of birth and year of immigration to Singapore. The TB registry tracks the progress and treatment outcome of each case, while the HIV registry captures CD4 cell counts, stage of HIV infection at diagnosis and mode of HIV detection.
Our study received ethics approval from the Singapore National Healthcare Group Domain Specific Review Board (NHG DSRB reference number 2015/00702). We retrospectively matched records between the HIV registry from 1985 to 2014 and the TB registry from 2000 to 2014. For TB cases with more than one notification, the first episodes were included in the study. The date of TB diagnosis is the earliest of the following dates: date treatment started, registration date, date of first positive smear, and date of first positive culture.
This study was confined to Singapore citizens and permanent residents. We defined TB and HIV coinfections as cases where the patient was diagnosed with HIV infection within 1 year of TB diagnosis, or diagnosed with HIV infection followed by TB. Of 798 matched records, 34 TB cases in which the patient had an HIV diagnosis > 1 year after TB diagnosis were excluded; none of them had multi-drugresistant TB (MDR-TB), i.e. resistance to both rifampicin and isoniazid. Data analysis was confined to 764 coinfected cases. The TB incidence density rate (IDR) was defined as the number of TB cases occurring per 100 person-years of observation with follow-up censored at TB diagnosis, death or 31 December 2014, whichever was the earliest date.
A chi-square test or Fisher's exact test was used to analyse differences between groups where appropriate. SPSS software, version 23 (IBM Corp., Armonk, NY, USA) was used for statistical analyses. A P-value < 0.05 was considered statistically significant.
Results
Between 2000 and 2014, a total of 23 150 TB cases (15 259 laboratory confirmed and 7891 clinically diagnosed) were reported, of which 764 (3.3%) were HIV positive (annual range, 2.6À4.7%) (Fig. 1) . Adults aged between 30 and 49 years contributed 55.5% of coinfections, while men and Chinese contributed 94.1% and 82.1%, respectively. Younger age, male gender, Chinese ethnicity and being Singapore-born were significantly associated with coinfection (all P < 0.0005) ( Table 1) .
About half (52.5%) of coinfected cases had both infections diagnosed within 1 month; 49.5% had only pulmonary TB; and 95.3% were newly diagnosed with TB. Compared with non-HIV-infected cases with TB, TB and HIV-coinfected cases were more likely to have extrapulmonary TB (EPTB) or both pulmonary and extrapulmonary TB, and a higher proportion were newly diagnosed with TB (all P < 0.0005). About 29.7% of EPTB cases were laboratory confirmed. The lymphatic system and pleura were the most common sites of infection in coinfected cases with EPTB and non-HIV-infected cases with EPTB, respectively. First-line DSTs were conducted in 650 TB and HIV-coinfected cases and 16 358 non-HIV-infected cases with TB in whom Mycobacterium tuberculosis complex (MTC) was detected, and resistance to isoniazid without rifampicin resistance was detected in 3.8% and 2.7% of coinfected cases and non-HIV-infected cases with TB, respectively (P = 0.088). The proportion of cases with MDR-TB was significantly higher in coinfected cases (0.9%) than in non-HIV-infected TB cases (0.4%) (P = 0.04) ( Table 1) .
Between 1985 and 2014, a total of 6685 cases of HIV infection were reported; 603 of them had a TB diagnosis on the same day or later, giving a TB IDR of 1.65 per 100 person-years. The proportion of coinfections among HIV-infected cases was highest in 2001, at 24.1%, and thereafter it declined continuously to 5.9% in 2014 (test for trend, P < 0.0005).
Compared with non-TB infected HIV cases, TB and HIV-coinfected cases were significantly more likely to have advanced HIV infection and a CD4 count < 200 cells/lL. They were more likely to have an HIV diagnosis through medical care and screening than non-TB infected HIV cases (82.1% versus 69.6%, respectively) and to have been infected via heterosexual contact (79.3% versus 56.5%, respectively) and injecting drug use (4.6% versus 1.4%, respectively) (all P < 0.0005) ( Table 1 ).
Discussion
Our study is one of the first in South East Asia to report TB and HIV coinfections by cross-matching 15 years of data from two national registries [6, 7] . The proportion of coinfections (2.9%) among TB cases between 2012 and 2014 was lower compared with that of countries in Asia with a high TB burden [8] . No particular trend in the annual proportion of coinfections was observed. The overall TB IDR among HIV-infected patients, at 1.65 per 100 person-years, was similar to that reported in the Asia-Pacific region (1.98 per 100 person-years) [9] . The proportion of coinfections among HIV cases plummeted from 24.1% in 2001 to 5.9% in 2014. In the same period, among all coinfections, the annual proportion of coinfections diagnosed within 1 month of each other increased, while that of cases having a TB diagnosis more than 1 month after an HIV diagnosis decreased. These findings suggest that the significant decline in the proportion of coinfections among HIV-infected patients could be attributable to early HIV diagnosis and highly active antiretroviral therapy (HAART).
Singapore-born residents constituted the vast majority of coinfected cases, unlike some Europe countries where foreign-born individuals have played an increasingly important role in the TB and HIV coinfection epidemiology [10, 11] . However, a local study reported increases in the number and proportion of foreign-born individuals with TB among long-term pass holders and permanent residents between 2000 and 2009 [12] . The impact of TB epidemiology on TB and HIV coinfections should be monitored closely. The patient category is defined as follows: new, patient who never previously received treatment for > 1 month; relapse, patient who previously completed treatment or was treated and declared cured prior to developing active TB again. ‡ Late-stage HIV infection was defined as having a CD4 count of < 200 cells/lL or developing AIDS-defining opportunistic infections at first diagnosis or within 1 year after HIV diagnosis.
More than a third (39.8%) of coinfected patients were aged ≥ 50 years, and these patients were reported to have lower CD4 counts at HIV diagnosis and a higher rate of active TB, and were more likely to have adverse clinical outcomes [13, 14] . Our findings reinforce the need to increase HIV awareness and improve prevention measures and screening services in this older age group.
About half of coinfected patients (53%) had diagnoses of TB and HIV infection within 1 month of each other. At the Tuberculosis Control Unit (TBCU), where nearly 70% of all Singapore residents with TB undergo treatment, more than 90% of patients with TB were screened for HIV between 2009 and 2011 (unpublished data by TBCU). However, the HIV screening rate at other TB treatment centres remained low, ranging between 7% and 56%. The take-up rate of HIV testing among patients with TB could be improved, especially at other TB treatment centres.
Compared with non-TB-infected HIV cases, coinfected cases were more likely to have advanced HIV infection at the time of HIV diagnosis. To encourage HIV testing for early detection, various measures have been implemented in Singapore, such as increasing the numbers of anonymous HIV testing sites and services offering rapid HIV testing, and provision of antenatal screening and inpatient voluntary opt-out HIV testing. Our study reported a low level of drug-resistant TB among coinfected cases (3.8%). However, Singapore is situated in a highly TB prevalent region and is a travel hub, with high traffic of visitors from countries with a high MDR-TB burden. Ongoing surveillance for drug-resistant TB is important to detect changes in local epidemiology.
Our study has a number of limitations. The true extent of coinfection is likely to be underestimated, as some TB or HIV infections may not have been diagnosed among the notified cases. Clinical information on viral load and use of HAART in coinfected cases was not available. As information on screening for latent TB and isoniazid prophylaxis was not available, we could not comment on TB services used by 32% of coinfected patients who developed TB more than 6 months after HIV diagnosis.
In conclusion, our findings reinforce the existing recommendations that all cases with a new TB diagnosis should be tested for HIV at the time of TB diagnosis and all cases newly diagnosed with HIV infection should be screened for latent and active TB for early diagnosis and treatment to combat the dual threat posed by these epidemics.
